Horan Securities’s Acer Therapeutics Inc ACER Stock Holding History

Horan Securities’s Portfolio ACER Stock Details ACER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-24	Closed	–	–	454
2020 Q3	$0	Buy	+24	New	+$78	﹤0.01%	407

Other funds holding ACER

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

HAG

HighPoint Advisor Group Downers Grove, Illinois $2.39B AUM 28.86% 1-Year Est. Return

Horan Securities's ACER Position: Q4 2020 in Review

Horan Securities sold out of Acer Therapeutics Inc (ACER) in Q4 2020, closing a stake of 24 shares.

Horan Securities first reported a position in ACER in Q3 2020 and held it in 1 quarter. The position peaked at $0 in Q3 2020. 30 funds tracked by Wall St. Rank hold ACER as of Q4 2020.

Horan Securities reported no remaining Acer Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
Horan Securities sold 24 Acer Therapeutics Inc shares in Q4 2020.
Horan Securities first reported a position in Acer Therapeutics Inc in Q3 2020 and held it in 1 quarter.
Horan Securities's Acer Therapeutics Inc position peaked at $0 in Q3 2020.
30 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q4 2020.

Based on Horan Securities's 13F filing for Q4 2020, filed 5 Feb 2021.